Through powerful research, the Melanoma Research Alliance (MRA) is quickly delivering results and saving lives. Over the past 10 years, MRA has invested $88 million - and leveraged an additional $89.5 million - to support 233 different research projects in 15 countries.
Read More
When we think about cancer researchers, we don’t always think of engineers. Dr. Ashish Kulkarni proves that maybe, we should. His pioneering work as a chemical engineer is helping us answer the critical, yet difficult to answer question that is at the forefront of every patient’s mind as they start treatment: ‘is it working?
Read More
In May 2017, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Pembrolizumab for treatmentof patients whose cancers possess a genetic mutation in the mismatch repair pathway (mismatch repair deficient, or dMMR) or are microsatellite instability-high (MSI-H).
Read More
Currently, Americans have access to 16 sunscreen active ingredients approved by the Food and Drug Administration (FDA) to prevent skin cancer. The last time a new OTC (Over the Counter) sunscreen ingredient was added to the FDA sunscreen monograph was 1999. Meanwhile, Europeans have access to 29 sunscreen active ingredients.
Read More
Your Cancer Game Plan is a resource for people with cancer and their loved ones focused on the emotional, health, and communication challenges of living with cancer. The online resource provides unique content including communication tips, coping strategies, and health and nutritional information, to help those with cancer and their caregivers take an active role in developing a “game plan” to support their journey.
Read More
10/20/2017 – Ten Years of Powerful Research and Results
10/10/2017 – “Seeing his Family Grow-Up Thanks to the Promise of Clinical Trials”
10/09/2017 – Safe and Sound: Balancing Safety with Innovation in American Sunscreens
10/06/2017 – Spotlight on Immunotherapy: Genetic Makeup of Tumors Informs use of anti-PD-1 drugs for Multiple Cancer Types
